Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
0LShkYUnwHYjHcqz
